X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ABBOTT INDIA AJANTA PHARMA/
ABBOTT INDIA
 
P/E (TTM) x 28.3 42.0 67.5% View Chart
P/BV x 11.7 10.5 111.4% View Chart
Dividend Yield % 0.5 0.6 80.2%  

Financials

 AJANTA PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
ABBOTT INDIA
Mar-16
AJANTA PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,7206,015 28.6%   
Low Rs1,1033,707 29.8%   
Sales per share (Unadj.) Rs194.61,236.9 15.7%  
Earnings per share (Unadj.) Rs45.2122.2 37.0%  
Cash flow per share (Unadj.) Rs50.3129.0 39.0%  
Dividends per share (Unadj.) Rs8.0035.00 22.9%  
Dividend yield (eoy) %0.60.7 78.7%  
Book value per share (Unadj.) Rs132.0521.2 25.3%  
Shares outstanding (eoy) m88.7721.25 417.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.33.9 184.6%   
Avg P/E ratio x31.239.8 78.5%  
P/CF ratio (eoy) x28.137.7 74.5%  
Price / Book Value ratio x10.79.3 114.6%  
Dividend payout %17.728.6 61.8%   
Avg Mkt Cap Rs m125,299103,296 121.3%   
No. of employees `000NA3.0 0.0%   
Total wages/salary Rs m2,5703,370 76.3%   
Avg. sales/employee Rs ThNM8,891.8-  
Avg. wages/employee Rs ThNM1,140.0-  
Avg. net profit/employee Rs ThNM878.3-  
INCOME DATA
Net Sales Rs m17,27526,284 65.7%  
Other income Rs m166504 33.0%   
Total revenues Rs m17,44226,789 65.1%   
Gross profit Rs m5,8073,665 158.4%  
Depreciation Rs m451144 312.0%   
Interest Rs m498 603.7%   
Profit before tax Rs m5,4744,017 136.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4601,421 102.7%   
Profit after tax Rs m4,0142,596 154.6%  
Gross profit margin %33.613.9 241.1%  
Effective tax rate %26.735.4 75.4%   
Net profit margin %23.29.9 235.2%  
BALANCE SHEET DATA
Current assets Rs m7,63914,446 52.9%   
Current liabilities Rs m2,7154,725 57.5%   
Net working cap to sales %28.537.0 77.1%  
Current ratio x2.83.1 92.0%  
Inventory Days Days4351 84.1%  
Debtors Days Days7920 402.2%  
Net fixed assets Rs m6,9141,113 621.2%   
Share capital Rs m177213 83.2%   
"Free" reserves Rs m11,44210,808 105.9%   
Net worth Rs m11,72111,076 105.8%   
Long term debt Rs m1490-   
Total assets Rs m14,81416,241 91.2%  
Interest coverage x112.9497.0 22.7%   
Debt to equity ratio x00-  
Sales to assets ratio x1.21.6 72.1%   
Return on assets %27.416.0 171.0%  
Return on equity %34.223.4 146.1%  
Return on capital %46.536.3 128.0%  
Exports to sales %55.10.6 8,969.9%   
Imports to sales %6.012.6 47.5%   
Exports (fob) Rs m9,527162 5,895.5%   
Imports (cif) Rs m1,0383,322 31.2%   
Fx inflow Rs m10,422268 3,888.7%   
Fx outflow Rs m1,6783,927 42.7%   
Net fx Rs m8,744-3,659 -238.9%   
CASH FLOW
From Operations Rs m3,2642,514 129.8%  
From Investments Rs m-2,093-800 261.8%  
From Financial Activity Rs m-1,186-803 147.7%  
Net Cashflow Rs m-15912 -1.6%  

Share Holding

Indian Promoters % 73.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 1.6 7.9 19.6%  
FIIs % 7.6 0.1 7,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 17.1 99.4%  
Shareholders   20,968 18,270 114.8%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  STRIDES SHASUN LTD  J.B.CHEMICALS  

Compare AJANTA PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 19, 2018 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS